Pharmanex Leads Nu Skin Growth in 2003

Measurement tool helps drive supplement purchases.

With a 19% increase in revenues during the fourth quarter last year and an 8% increase overall in 2003, the Pharmanex division of Nu Skin Enterprises is enjoying healthy growth. Pharmanex generated $472.1 million in 2003, driven by strong sales which outpaced Nu Skin’s 2% overall revenue growth. By the end of fiscal year 2003, Pharmanex’s nutritional sales represented 48% of total Nu Skin sales of $987 million, up from 46% in 2002.

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.